Maripier Isabelle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maripier Isabelle has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abdel-Hamid Bello
Université du Québec à Montréal, Canada; GRIP, Canada
1 shared publication Audrey Laporte
Institute of Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada
1 shared publicationBernard Fortin
1 shared publication- Boriana Miloucheva
Center for Health and Wellbeing Princeton University Princeton New Jersey USA
1 shared publication - Guy Lacroix
Department of Economics, Université Laval, Québec, Canada
1 shared publication - Jill Furzer
Institute of Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by Elsevier in Economics & Human Biology
- Vol. 62, 101631
Prenatal exposure to PM2.5 and infant health: Evidence from Quebec
- 30 July 2026
- Published by Elsevier in Economics & Human Biology
- Vol. 62, 101631
Open AccessPrenatal exposure to PM2.5 and infant health: Evidence from Quebec
- Open Access
- 13 September 2025
- Published by Elsevier in Journal of Economic Behavior & Organization
- Vol. 238
Demand for domestic help services: Evidence from a natural experiment
- 13 September 2025
- Published by Elsevier in Journal of Economic Behavior & Organization
- Vol. 238
Open AccessDemand for domestic help services: Evidence from a natural experiment
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
How Do Physicians Respond to New Medical Research?
What happens when the findings of a prominent medical study are overturned? Using a medical trial on breech births, we estimate the effect of the reversal of such a medical study on physician choices and infant health outcomes. Using the United States Birth Certificate Records from 1995-2010, we employ a difference-in-differences estimator for C-sections, low Apgar, and low birth weight measures. We find that the reversal of a multi-site, high profile, randomized control trial on the appropriate delivery of term breech births, the Term Breech Trial (TBT), led to a 15-23 percent decline in C-sections for such births at a time when the overall trend in C-sections was rising. We find our largest estimated effects amongst traditionally disadvantaged groups. However, we do not find that such a change in practice had significant impacts on infant health. Contrary to prior studies, we find that physicians updated their beliefs quickly, and do indeed adjust to new medical research, particularly young physicians, prior to mandatory policy or professional guidelines.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessHow Do Physicians Respond to New Medical Research?
What happens when the findings of a prominent medical study are overturned? Using a medical trial on breech births, we estimate the effect of the reversal of such a medical study on physician choices and infant health outcomes. Using the United States Birth Certificate Records from 1995-2010, we employ a difference-in-differences estimator for C-sections, low Apgar, and low birth weight measures. We find that the reversal of a multi-site, high profile, randomized control trial on the appropriate delivery of term breech births, the Term Breech Trial (TBT), led to a 15-23 percent decline in C-sections for such births at a time when the overall trend in C-sections was rising. We find our largest estimated effects amongst traditionally disadvantaged groups. However, we do not find that such a change in practice had significant impacts on infant health. Contrary to prior studies, we find that physicians updated their beliefs quickly, and do indeed adjust to new medical research, particularly young physicians, prior to mandatory policy or professional guidelines.
- 31 January 2023
- Published by Elsevier in Journal of Economic Behavior & Organization
- Vol. 207, 327-349
The incubated revolution: Education, cohort effects, and the linguistic wage gap in Quebec during the 20th century
- 31 January 2023
- Published by Elsevier in Journal of Economic Behavior & Organization
- Vol. 207, 327-349
The incubated revolution: Education, cohort effects, and the linguistic wage gap in Quebec during the 20th century
- 21 November 2022
- Published by Wiley in Health Economics
- Vol. 32 (2) , 518-538
Public drug insurance, moral hazard and children's use of mental health medication: Latent mental health risk‐specific responses to lower out‐of‐pocket treatment costs
Studies have shown that reducing out‐of‐pocket costs can lead to higher medication initiation rates in childhood. Whether the cost of such initiatives is inflated by moral hazard issues remains a question of concern. This paper looks to the implementation of a public drug insurance program in Québec, Canada, to investigate potential low‐benefit consumption in children. Using a nationally representative longitudinal sample, we harness machine learning techniques to predict a child's risk of developing a mental health disorder. Using difference‐in‐differences analyses, we then assess the impact of the drug program on children's mental health medication uptake across the distribution of predicted mental health risk. Beyond showing that eliminating out‐of‐pocket costs led to a 3 percentage point increase in mental health drug uptake, we show that demand responses are concentrated in the top two deciles of risk for developing mental health disorders. These higher‐risk children increase take‐up of mental health drugs by 7–8 percentage points. We find even stronger effects for stimulants (8–11 percentage point increases among the highest risk children). Our results suggest that reductions in out‐of‐pocket costs could achieve better uptake of mental health medications, without inducing substantial low‐benefit care among lower‐risk children.
- 21 November 2022
- Published by Wiley in Health Economics
- Vol. 32 (2) , 518-538
Public drug insurance, moral hazard and children's use of mental health medication: Latent mental health risk‐specific responses to lower out‐of‐pocket treatment costs
Studies have shown that reducing out‐of‐pocket costs can lead to higher medication initiation rates in childhood. Whether the cost of such initiatives is inflated by moral hazard issues remains a question of concern. This paper looks to the implementation of a public drug insurance program in Québec, Canada, to investigate potential low‐benefit consumption in children. Using a nationally representative longitudinal sample, we harness machine learning techniques to predict a child's risk of developing a mental health disorder. Using difference‐in‐differences analyses, we then assess the impact of the drug program on children's mental health medication uptake across the distribution of predicted mental health risk. Beyond showing that eliminating out‐of‐pocket costs led to a 3 percentage point increase in mental health drug uptake, we show that demand responses are concentrated in the top two deciles of risk for developing mental health disorders. These higher‐risk children increase take‐up of mental health drugs by 7–8 percentage points. We find even stronger effects for stimulants (8–11 percentage point increases among the highest risk children). Our results suggest that reductions in out‐of‐pocket costs could achieve better uptake of mental health medications, without inducing substantial low‐benefit care among lower‐risk children.